Mandate Details

Description:	Program review of whether manufacturers are reimbursing pharmacies for urgent-need insulin; determining eligibility in a timely manner and notifying individuals; and providing pharmacies with insulin product under the manufacturers' patient assistance program; whether training for navigators is adequate and accessible, and whether there is a sufficient number of trained navigators.
Law:	2020 Minn. Laws Chap. 73 Sec. 4 Subd. 14
Statute:	151.74 Subd. 14
Agency(ies)/Supplier(s):	Minn. Legislature - Office of the Legislative Auditor
Due Date:
Frequency:	One time
Subjects:	Health Care - Pharmaceuticals
Note:	"The legislative auditor is requested to conduct a program review" The Office of the Legislative Auditor reports that they do not have a review of the urgent-need insulin program in progress at this time. (April 2021)

No items received for this mandate.